13 reports of this reaction
3.1% of all FLUPHENAZINE HYDROCHLORIDE reports
#3 most reported adverse reaction
ANXIETY is the #3 most commonly reported adverse reaction for FLUPHENAZINE HYDROCHLORIDE, manufactured by Rising Pharma Holdings, Inc.. There are 13 FDA adverse event reports linking FLUPHENAZINE HYDROCHLORIDE to ANXIETY. This represents approximately 3.1% of all 426 adverse event reports for this drug.
Patients taking FLUPHENAZINE HYDROCHLORIDE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is moderately reported among FLUPHENAZINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to anxiety, the following adverse reactions have been reported for FLUPHENAZINE HYDROCHLORIDE:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 13 FDA reports for FLUPHENAZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 3.1% of all adverse event reports for FLUPHENAZINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience anxiety while taking FLUPHENAZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.